ATE428787T1 - Fragment aus dem genom von streptococcus suis und seine klinische verwendungen - Google Patents

Fragment aus dem genom von streptococcus suis und seine klinische verwendungen

Info

Publication number
ATE428787T1
ATE428787T1 AT01993615T AT01993615T ATE428787T1 AT E428787 T1 ATE428787 T1 AT E428787T1 AT 01993615 T AT01993615 T AT 01993615T AT 01993615 T AT01993615 T AT 01993615T AT E428787 T1 ATE428787 T1 AT E428787T1
Authority
AT
Austria
Prior art keywords
fragment
genome
streptococcus
streptococcus suis
clinical uses
Prior art date
Application number
AT01993615T
Other languages
English (en)
Inventor
Hilda Smith
Original Assignee
Id Lelystad Inst Dierhouderij
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Lelystad Inst Dierhouderij filed Critical Id Lelystad Inst Dierhouderij
Application granted granted Critical
Publication of ATE428787T1 publication Critical patent/ATE428787T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01993615T 2000-11-09 2001-11-06 Fragment aus dem genom von streptococcus suis und seine klinische verwendungen ATE428787T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203947A EP1205552A1 (de) 2000-11-09 2000-11-09 Streptokokkenvirulenz mit ORF aus Streptococcus suis
PCT/NL2001/000805 WO2002038597A2 (en) 2000-11-09 2001-11-06 Genomic fragment of streptococcus suis and clinical uses thereof

Publications (1)

Publication Number Publication Date
ATE428787T1 true ATE428787T1 (de) 2009-05-15

Family

ID=8172250

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01993615T ATE428787T1 (de) 2000-11-09 2001-11-06 Fragment aus dem genom von streptococcus suis und seine klinische verwendungen

Country Status (9)

Country Link
US (3) US7109006B2 (de)
EP (2) EP1205552A1 (de)
AT (1) ATE428787T1 (de)
AU (1) AU2002224207A1 (de)
CA (1) CA2428278C (de)
DE (1) DE60138408D1 (de)
DK (1) DK1334196T3 (de)
ES (1) ES2325911T3 (de)
WO (1) WO2002038597A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000005378A2 (en) 1998-07-22 2000-02-03 Id-Lelystad Instituut Voor Dierhouderij En Diergezondheid B.V. Streptococcus suis vaccines and diagnostic tests
EP1205552A1 (de) 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Streptokokkenvirulenz mit ORF aus Streptococcus suis
WO2002061070A2 (en) 2001-02-02 2002-08-08 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes, involved in the virulence of streptococcus suis
US6962485B2 (en) * 2003-04-14 2005-11-08 Goodrich Pump And Engine Control Systems, Inc. Constant bypass flow controller for a variable displacement pump
EP2023143A1 (de) * 2007-08-06 2009-02-11 Boehringer Ingelheim Vetmedica Gmbh Immunogene Streptokokkus-Proteine
CN103409546B (zh) * 2013-08-20 2015-05-20 长沙市疾病预防控制中心 一种用于检测猪链球菌2型的试剂盒及其应用
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP4159231A1 (de) 2016-11-11 2023-04-05 Boehringer Ingelheim Vetmedica GmbH Abschwächen bakterieller virulenz durch abschwächen des bakteriellen folattransports
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN110938636B (zh) * 2019-12-05 2023-05-26 中国水产科学研究院黑龙江水产研究所 鲁氏耶尔森菌溶血素基因的主要致病性片段及筛选方法和应用
CN118603963B (zh) * 2024-08-01 2024-11-19 浙江大学 一种快速鉴定无乳链球菌及其高毒力株的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9100510A (nl) 1991-03-21 1992-10-16 Centraal Diergeneeskundig Inst Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
US5928900A (en) 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
WO1995031548A1 (en) 1994-05-16 1995-11-23 The Uab Research Foundation Streptococcus pneumoniae capsular polysaccharide genes and flanking regions
US5681570A (en) 1995-01-12 1997-10-28 Connaught Laboratories Limited Immunogenic conjugate molecules
EP0750043B1 (de) 1995-06-20 2001-05-23 Societe Des Produits Nestle S.A. Exopolysaccharide-produzierende Milchsäurebakterien
EP0750042A1 (de) 1995-06-20 1996-12-27 Societe Des Produits Nestle S.A. Exopolysaccharide-produzierende Milchsäurebakterien
JP2001510989A (ja) 1996-11-01 2001-08-07 スミスクライン・ビーチャム・コーポレイション 新規コーディング配列
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
WO2000005378A2 (en) * 1998-07-22 2000-02-03 Id-Lelystad Instituut Voor Dierhouderij En Diergezondheid B.V. Streptococcus suis vaccines and diagnostic tests
CN1318103A (zh) * 1998-07-27 2001-10-17 微生物技术有限公司 肺炎链球菌的核酸和蛋白质
EP1205552A1 (de) 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Streptokokkenvirulenz mit ORF aus Streptococcus suis
WO2002061070A2 (en) 2001-02-02 2002-08-08 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes, involved in the virulence of streptococcus suis

Also Published As

Publication number Publication date
EP1334196B8 (de) 2009-09-02
EP1334196B1 (de) 2009-04-15
DK1334196T3 (da) 2009-07-06
CA2428278C (en) 2011-08-23
US20100136057A1 (en) 2010-06-03
WO2002038597A3 (en) 2002-08-08
WO2002038597A2 (en) 2002-05-16
US8071111B2 (en) 2011-12-06
EP1205552A1 (de) 2002-05-15
AU2002224207A1 (en) 2002-05-21
EP1334196A2 (de) 2003-08-13
US7109006B2 (en) 2006-09-19
DE60138408D1 (de) 2009-05-28
US20040009192A1 (en) 2004-01-15
US7670835B2 (en) 2010-03-02
US20070053938A1 (en) 2007-03-08
CA2428278A1 (en) 2002-05-16
ES2325911T3 (es) 2009-09-24

Similar Documents

Publication Publication Date Title
ATE428787T1 (de) Fragment aus dem genom von streptococcus suis und seine klinische verwendungen
Evans et al. Genetic markers unique to Listeria monocytogenes serotype 4b differentiate epidemic clone II (hot dog outbreak strains) from other lineages
WO2002000927A3 (en) Diagnosis of diseases associated with development by means of assessing their methylation status
Woo et al. Identification of pathogenic Leptospira genospecies by continuous monitoring of fluorogenic hybridization probes during rapid-cycle PCR
WO2003066803A3 (en) Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
EP1576145A4 (de) Bioinformatisch nachweisbare gruppe neuer viraler regulatorischer gene und verwendungen davon
DK1196637T3 (da) Peptidacceptor-ligeringsmetoder
AU7710200A (en) Method and compositions for improved polynucleotide synthesis
EP1668148A4 (de) Nukleinsäurenachweistest
DE69609161D1 (de) Amplifikationsoligonukleotide und sonden für borrelia, die mit lyme kranheit assoziiert sind
WO1996006949A3 (en) Nucleic acid hybridization assay probes targeted to mycoplasma pneumoniae nucleic acid
DE60132924D1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
WO2002061070A8 (en) Environmentally regulated genes, involved in the virulence of streptococcus suis
WO2005001142A3 (en) Methods and nucleic acids for the analysis of colorectal cell proliferative disorders
Woo et al. Real-time homogeneous assay of rapid cycle polymerase chain reaction product for identification ofLeptonema illini
DE19901827A1 (de) Streptococcus-agalactiae-spezifisches DNA-Fragment und damit verwandte Nucleinsäuremoleküle
WO2003002587A3 (en) Phosphoramide containing nucleic acid-based compounds and libraries as antivirals
WO2002044406A3 (en) Projection against mycobacterial infections
WO2002036814A3 (de) Diagnose von mit cdk4 assoziierten krankheiten durch bestimmung des methylierungszustandes des cdk4
WO2002012554A3 (de) Diagnose von mit cd24 assoziierten krankheiten
Hookey et al. Use of fluorescent amplified fragment length polymorphism (fAFLP) to characterise methicillin-resistant Staphylococcus aureus
WO2004029216A3 (en) Diagnosis of invasive mold infection
Roy et al. A 22‐mer primer enhances discriminatory power of AP‐PCR fingerprinting technique in characterization of leptospires
GB2362212A (en) Method for the identification and speciation of bacteria of the burkholderia cepacia complex
DE50111824D1 (de) Diagnose von mit humos assoziierten krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties